Home1099 • HKG
add
Sinopharm Group Co Ltd
Previous close
$20.55
Day range
$19.80 - $20.85
Year range
$16.02 - $23.65
Market cap
62.57B HKD
Avg Volume
9.37M
P/E ratio
6.73
Dividend yield
4.77%
Primary exchange
HKG
In the news
Financials
Income Statement
Revenue
Net income
| (CNY) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 147.36B | -5.19% |
Operating expense | 6.78B | 4.18% |
Net income | 1.85B | -26.34% |
Net profit margin | 1.26 | -22.22% |
Earnings per share | — | — |
EBITDA | 4.76B | -25.05% |
Effective tax rate | 22.34% | — |
Balance Sheet
Total assets
Total liabilities
| (CNY) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 43.33B | 26.05% |
Total assets | 429.58B | 2.85% |
Total liabilities | 307.15B | 0.84% |
Total equity | 122.43B | — |
Shares outstanding | 3.12B | — |
Price to book | 0.85 | — |
Return on assets | 2.44% | — |
Return on capital | 4.69% | — |
Cash Flow
Net change in cash
| (CNY) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | 1.85B | -26.34% |
Cash from operations | -20.50B | -678.47% |
Cash from investing | -519.26M | -167.92% |
Cash from financing | 10.78B | 5,713.58% |
Net change in cash | -10.24B | -512.13% |
Free cash flow | 2.71B | 108.45% |
About
Sinopharm Group Co., Ltd. is a Chinese pharmaceutical company. The parent company of Sinopharm Group was Sinopharm Industrial Investment, a 51–49 joint venture of state-owned enterprise China National Pharmaceutical Group and civilian-run enterprise Fosun Pharmaceutical.
Its H shares were listed on the Hong Kong Stock Exchange in 2009, with its IPO price of HK$16 per share. Sinopharm Group's subsidiary Sinopharm CNMC and Sinopharm Accord served as the A share counterpart of the company. However, the A share of Sinopharm Group itself was unlisted.
Sinopharm Group was ranked 829th in 2016 Forbes Global 2000 list. Wikipedia
Founded
2003
Website
Employees
113,635
